tiprankstipranks
Tilray Jumps on Possible Legalization of Marijuana
Market News

Tilray Jumps on Possible Legalization of Marijuana

Cannabis stocks registered substantial gains, following news of possible legalization of marijuana at the federal level next week. The U.S. House of Representatives is likely to vote for the second time on the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act headed by House Judiciary Committee Chairman, Jerrold Nadler (D-NY). 

Notably, the MORE Act previously passed the House in December 2020 but was obstructed in the Senate. 

Among other cannabis stocks, shares of Tilray Brands, Inc. (TLRY), the global pharmaceutical, cannabis-lifestyle, and consumer packaged goods company, climbed 17.8% during Thursday’s extended trading session, after closing almost 22% higher on the day. 

Investors Remain Cautious  

Turning to Wall Street, Tilray has a Hold consensus rating, based on three Buys, seven Holds, and one Sell. The average Tilray price target of $10.21 implies 46.48% upside potential to current levels. 

Furthermore, TipRanks’ Stock Investors tool shows that investors currently have a Neutral stance on Tilray, with investors maintaining portfolios on TipRanks, decreasing their exposure to TLRY stock over the past seven days. 

Meanwhile, Tilray gets a 1 out of 10 on TipRanks’ Smart Score ranking, suggesting that TLRY is likely to underperform market expectations. 

Download the TipRanks mobile app now 

To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights. 

Read full Disclaimer & Disclosure 

Related News: 
Novavax’s COVID-19 Vaccine Obtains EUA for Adolescents in India 
BP Hopes to Sell Shut-Down North Sea Oilfield 
GameStop Jumps 14.5% on Cohen’s Stake Increase

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles